Duocetz

Quick links to important sections

Duocetz

Treatment option: Pain

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Duocetz

Property Description
Active Ingredients Tramadol Hydrochloride, Acetaminophen (Paracetamol)
Form Film-coated tablet
Pharmacological Class Fixed-dose narcotic analgesic combination
Common Use Management of moderate to severe pain
Origin Synthetic/semi-synthetic combination

What Type of Pain Reliever is Duocetz?

Duocetz is classified as a fixed-dose combination analgesic, a prescription-only medicinal product specifically used for pain management. It falls under the pharmacological class of narcotic analgesic combinations, which signifies the inclusion of a powerful, centrally acting opioid component alongside a non-opioid pain reliever. The product is a synthetic medicinal entity intended for systemic analgesia, meaning it acts throughout the body via the bloodstream, contrasting with localized, topical pain relievers. This dual-compound design is clinically recognized for achieving enhanced antinociceptive action by addressing the pain signaling process through complementary mechanisms.


Composition and Form: Acetaminophen and Tramadol Hydrochloride

The preparation contains the two active ingredients, Tramadol Hydrochloride and Acetaminophen (Paracetamol), which are delivered together as a film-coated tablet via the oral route. Tramadol is a centrally acting substance, while Acetaminophen primarily works within the central nervous system to influence pain perception. As a fixed-dose combination product, the two distinct analgesic compounds are precisely combined within a single tablet. This dual composition is engineered to harness the clinical benefit of two different pain relief modalities simultaneously, a distinguishing feature compared to single-agent preparations. This type of formulation is often employed when managing discomfort that requires a multifaceted approach.


How Does This Combination Affect Pain Sensation?

The primary purpose of the Tramadol and Acetaminophen combination is to manage moderate to severe pain by employing a dual approach that modulates pain signals in the nervous system. The simultaneous action of the two compounds provides superior relief compared to using either component alone. This means the combination provides a robust therapeutic benefit that helps ease discomfort more effectively by tackling the pain pathway in multiple ways. This strategy ensures that the medication does not rely on a single pathway for its effect; the synthetic opioid component and the non-opioid analgesic work concurrently, offering a comprehensive and potent approach to pain relief. The benefit of this combined action is providing comprehensive coverage for pain, such as temporary pain relief following minor surgical procedures.

Regulatory References

  1. NIH Study on Combination Analgesic Efficacy

What side effects are possible with Duocetz?

Possible Side Effects and Safety Information

The official safety information for this combination medication is structured by government regulatory bodies to define the characteristics and potential frequency of possible effects, strictly based on documented label information.

Frequency-Classified Adverse Reactions

Adverse reactions are formally categorized according to their expected occurrence, as defined in regulatory documents such as the FDA Prescribing Information and the SmPC. The most frequent reactions affect the nervous and gastrointestinal systems:

  • Very Common (affecting more than 1 in 10 people): Nausea, Dizziness, and Somnolence (Drowsiness).
  • Common (affecting 1 to 10 in 100 people): Vomiting, Constipation, Dry mouth, Headache, Sweating, and Fatigue.

Serious Adverse Reactions and Key Constraints

Regulatory labeling specifies high-level safety warnings concerning potentially life-threatening but less frequent events:

Category Documented Safety Statement
Critical Organ Risk Risk of life-threatening Respiratory Depression, especially upon treatment initiation or dose increase. Risk of Hepatotoxicity (severe liver damage) due to the acetaminophen component.
Nervous System Official warnings concerning the potential for Seizures and the risk of Serotonin Syndrome (especially with co-administered serotonergic agents).
Safety Constraints Contraindicated in patients under 12 years of age, in those with severe hepatic impairment, and in those using MAO Inhibitors or within 14 days of stopping them.

Certain serious risks, such as Respiratory Depression, are officially noted as being most likely during the initial 24 to 72 hours of treatment. Prolonged use is associated with a risk of physical dependence.

Overdose and Emergency Response

Overdose of Duocetz, a combination of Tramadol and Acetaminophen, presents a dual-toxicity profile requiring immediate emergency assessment as stated in regulatory documents. Overdose manifestations include symptoms related to both components.

The opioid component (Tramadol) is associated with severe central nervous system (CNS) depression, leading to documented signs such as life-threatening respiratory depression, confusion, severe drowsiness, seizure, and pinpoint pupils. The non-opioid component (Acetaminophen) carries the risk of severe hepatotoxicity, or acute liver failure, which may be delayed in onset but can be fatal. Early symptoms of acetaminophen toxicity may include nausea, vomiting, sweating, and abdominal discomfort.

In the event of a suspected or known overdose, the government-mandated action is to seek immediate medical attention for emergency treatment. This action is required even if the person feels well due to the delayed risk of severe liver damage. Officially documented management protocols for overdose necessitate symptomatic and supportive measures, including close monitoring of respiratory status.

Treatment requires the use of two specific antidotes: Naloxone to reverse acute opioid effects and N-acetylcysteine (NAC) to mitigate acetaminophen-induced liver damage. Regulatory documents note an increased risk of fatal overdose in children from accidental ingestion and increased susceptibility to hepatotoxicity in patients with underlying liver disease.

Therapeutic Uses of Duocetz

What Duocetz Treats: Main Uses and Benefits

Duocetz is specifically applied in situations involving symptoms related to physical discomfort characterized as moderate to severe pain, and may be relevant when symptoms are not adequately addressed by non-opioid medications. The combination is commonly used for managing symptoms related to pain of a level that may require opioid support. This support for pain helps ease the overall symptom burden, offering relief that assists patients in coping more steadily with difficult episodes.

This medication is relevant across conditions characterized by periods of heightened symptoms, including symptomatic support during acute periods following surgical procedures, management of discomfort due to trauma or injuries, and the symptomatic treatment of exacerbations of chronic musculoskeletal disorders like chronic lower back pain or osteoarthritis. The support may contribute to easing discomfort during these phases, assisting with maintaining functional stability. Furthermore, Duocetz may assist with symptomatic management by addressing pain alongside the potential for associated febrile symptoms (fever).

“The combination is applied in situations where symptoms create noticeable physiological strain and requires supportive symptomatic relief.”

Quick Fact: Relief for Acute and Chronic Pain Duocetz is commonly used when supportive symptomatic assistance is appropriate for significant physical discomfort and is also applicable for managing flare-ups of chronic conditions.

Regulatory References

  1. NIH DailyMed on Tramadol and Acetaminophen

Eligibility and Restrictions for Use

Who can and cannot use Duocetz?

Eligibility for Duocetz (Tramadol/Acetaminophen) is determined by regulatory labels and is highly restricted due to its fixed-dose combination, particularly the opioid component.


Approved and Non-Eligible Populations

Duocetz is approved for use in Adults and Adolescents aged 12 years and older.

It is contraindicated in several groups, including children under 12 years and adolescents under 18 years for postoperative pain management following tonsillectomy or adenoidectomy.


Absolute Contraindications (Must Not Use)

Patients must not use Duocetz if they have:

  • Severe hepatic impairment.
  • Significant respiratory depression or severe bronchial asthma.
  • Known or suspected gastrointestinal obstruction (e.g., paralytic ileus).
  • Uncontrolled epilepsy or unmanaged seizure disorder.
  • Acute intoxication with alcohol or other central nervous system depressants.
  • Concurrent use of Monoamine Oxidase Inhibitors (MAOIs) or use within the last 14 days.

Special Condition Restrictions

  • Pregnancy and Lactation: Use is not recommended due to the risk of Neonatal Opioid Withdrawal Syndrome and drug excretion into breast milk.
  • Severe Renal Impairment: Use is generally not recommended.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Duocetz, a combination of tramadol and acetaminophen, has a strictly documented interaction profile based on authoritative regulatory guidance. Interactions are categorized by their severity and mechanism, requiring careful consideration of co-administered substances.

Contraindicated Combinations

The product is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs), including non-selective, selective-B, or within 14 days of discontinuing an MAOI. It must also not be used with other medicines containing tramadol or acetaminophen.

Clinically Significant Interactions

Interaction Type Interacting Substances Official Concern
Pharmacodynamic Serotonergic drugs (SSRIs, SNRIs, Triptans), CNS Depressants (Alcohol, Benzodiazepines) Risk of Serotonin Syndrome, profound sedation, and respiratory depression.
Pharmacokinetic CYP2D6 or CYP3A4 inhibitors/inducers (e.g., Quinidine, Carbamazepine) Altered plasma concentration and efficacy of tramadol and its active metabolite.

Other Documented Requirements

Official labeling notes that the product may increase the risk of elevated International Normalized Ratio (INR) in patients taking oral anticoagulants like Warfarin. Furthermore, specific patient populations, such as those with severe hepatic impairment or ultra-rapid metabolizers, have heightened interaction-related considerations noted in prescribing information.

Mechanism of Action

How Duocetz Works — Mechanism of Action

Duocetz utilizes a combined multimodal mechanism that focuses on modulating nociceptive signaling primarily within the central nervous system (CNS). This approach simultaneously targets three distinct biological systems to contribute to multimodal modulation of nociception.

Dual Modulation of Central Pain Pathways

The Tramadol component acts via a dual mechanism. Its active metabolite functions as an agonist at the mu-opioid receptor (MOR), which suppresses the upward transmission of nociceptive signals from the spinal cord. Concurrently, Tramadol inhibits the reuptake of Norepinephrine (NE) and Serotonin (5-HT). This monoaminergic action augments activity in the descending inhibitory pathways, augmenting endogenous modulation of nociceptive input.

Central Elevation of the Nociceptive Threshold

The Acetaminophen component modulates the activity of Cyclooxygenase (COX) enzymes primarily within the CNS. This modulation reduces the synthesis of Prostaglandin E2 ( PGE2), a mediator that influences neuronal excitability. The physiological consequence is a functional elevation of the central nociceptive threshold, meaning a stronger stimulus is required for the nervous system to register the input as nociceptive.

Multitargeting Mechanistic Synergy

The combination achieves synergy by coordinating MOR agonism, monoamine reuptake inhibition, and central prostaglandin modulation. This multitargeting approach inhibits the propagation of nociceptive signals while simultaneously altering the CNS's overall sensitivity, leading to a robust multimodal modulation of nociceptive signaling.

Dosage and Administration Information

How Duocetz is Administered

Duocetz (Tramadol Hydrochloride/Acetaminophen) is administered exclusively via the oral route as a film-coated tablet. The general use principles are defined by official dosing limits and strict scheduling to manage its analgesic components, based on established clinical guidelines.

Standard Labeled Regimen

The established regimen for adults involves an initial dose of two tablets (75 mg Tramadol/650 mg Acetaminophen). Subsequent doses are typically one to two tablets as needed. A key constraint of the administration is the minimum interval; doses must be separated by no less than six hours. In a 24-hour period, the total consumption must not exceed the maximum limit of eight tablets.

Administration Constraint Instruction as per Label
Route and Method Swallowed whole with liquid; must not be crushed or split.
Duration Restricted to short-term use, often limited to five days or less for acute symptoms.
Food Relationship May be taken with or without food.
Concurrent Use Avoid all other products containing Acetaminophen or Tramadol.

Population-Specific Use

Specific scheduling adjustments are required for certain populations. For patients with moderate renal impairment (creatinine clearance 10 –30 mL/min), the dosing interval is extended to 12-hourly to account for altered clearance. The use of Duocetz is not recommended for children under 12 years of age or in cases of severe renal impairment.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Duocetz

The clinical research for the fixed-dose combination of Tramadol and Acetaminophen (Duocetz) was studied for its use in managing different types of physical discomfort. The evidence is derived primarily from randomized controlled trials (RCTs) and systematic reviews, which are the types of studies used in research relevant in trials assessing short-term or episodic symptom patterns. Research highlights what is known — and what is still uncertain — about these findings.


Evidence for Use in Acute Pain Management

This section summarizes the structure of the clinical research, focusing on short-term randomized controlled trials (RCTs) and systematic reviews that have examined the combination for pain immediately following procedures like dental or minor surgery.

Study Designs and Measured Outcomes for Acute Pain

Studies focused on generally healthy adults who were experiencing moderate to severe outcomes related to physical discomfort following routine medical procedures. Researchers monitored patient-reported outcomes describing perceived discomfort using metrics such as the Total Pain Relief (TOTPAR) scale, which is a standardized scale for measuring changes in pain status, and the time required for a patient to experience measurable pain change.

Studies described patterns where the measured outcomes related to physical discomfort (such as TOTPAR) were often numerically higher for the combination when compared to the inactive placebo. Outcomes reported were also numerically greater than those described for the single active ingredients when administered separately. Research highlights changes measured during the study period, but the focus is strictly on the immediate effects, with study periods generally not exceeding one week.


Evidence for Use in Chronic Pain Management

This section will outline the types of intermediate-term studies and trials available that have investigated the fixed-dose combination in conditions characterized by persistent discomfort, such as osteoarthritis and chronic lower back pain. These are conditions marked by functional limitations and where symptoms may vary in intensity.

Functional Measures and Efficacy Comparisons in Chronic Pain Trials

Research has explored the combination in adults diagnosed with chronic conditions associated with functional limitations. The outcomes monitored were not just pain scores, but also outcomes reflecting daily functioning or activity level, measured using tools like the Roland Disability Questionnaire (RDQ).

Intermediate-term trials, typically lasting up to three months, examined changes when the combination was observed against an inactive placebo. The evidence base contributes to understanding symptom patterns, but findings concerning measured outcomes reflecting daily functioning were inconsistent across studies. Research describes that the data collected suggested heterogeneity in patient response during the study period.


What is Still Uncertain About the Research for Duocetz

Certainty remains low regarding long-term data related to specific functional outcomes for the combination. Follow-up durations were limited in many of the key chronic pain trials, meaning the relationship between short-term findings and long-term activity level is not fully established. Comparative evidence is lacking for specific subsets of pain conditions, and subgroup findings are uncertain for those with comorbidities. Research does not determine whether an individual will respond similarly; study results reflect the specific conditions under which they were conducted.

Key Studies & References

  1. FDA Approved Drug Products: Label and Patient Information for Acetaminophen and Tramadol Hydrochloride Fixed Dose Combination
  2. Chronic Pain (Primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. (NICE Guideline NG193)

Frequently Asked Questions (FAQ)

Common questions about Duocetz (FAQ)

Q: Does Duocetz need to be taken at the same exact time every day?

A: Official guidance for Duocetz, an immediate-release combination, emphasizes adhering to the minimum dosing interval and not exceeding the maximum daily limit. Regulatory documents focus on ensuring doses are properly spaced (e.g., no less than six hours apart), rather than requiring that every dose be taken at the exact same time each day.

Q: What if I'm taking vitamins or herbal supplements—do they interact with Duocetz?

A: Yes, official regulatory documents specifically advise caution regarding certain supplements. The product is described as being used with caution when combined with serotonergic substances, which includes certain herbal supplements like St. John’s Wort, due to the potential risk of a serious condition called Serotonin Syndrome.

Q: What is the meaning of the research term 'efficacy' in relation to Duocetz?

A: The term efficacy, as used in research reports and official documents, refers to how well the medicine achieved its intended effect of pain relief under the controlled conditions of clinical trials compared to an inactive substance (a placebo). It is a measurement of the potential benefit observed.

Q: Does Duocetz have a warning about driving or operating machinery?

A: Official labeling includes a clear warning about performing potentially hazardous tasks. Due to side effects such as dizziness and drowsiness (somnolence), the medicine may impair the mental or physical abilities required for activities like driving a car or operating machinery.

Q: What is the risk of an allergic reaction to Duocetz?

A: Safety information in regulatory documents warns of the potential for hypersensitivity reactions, which include serious events such as rash, hives, and potentially fatal anaphylactoid reactions. The medicine is generally described as being contraindicated for patients with a known history of hypersensitivity to the components.

Q: Can I crush or split the Duocetz tablet?

A: Regulatory guidance explicitly states that the tablet must be swallowed whole and should not be crushed or split. Regulatory labeling indicates that this restriction is necessary because altering the tablet can lead to the uncontrolled release of the active ingredients, posing a serious safety risk related to overdose.

Q: Does Duocetz interact with alcohol, and what does the official guidance say?

A: Yes, regulatory warnings note a serious interaction. The combination of Duocetz with alcohol may result in profound sedation, respiratory depression, coma, and death, as alcohol acts as a Central Nervous System (CNS) depressant. Official regulatory warnings describe that patients should not consume alcohol-containing beverages while using the product.

Q: Can Duocetz cause changes to my blood pressure?

A: Regulatory safety data indicates that this medicine has been associated with changes in blood pressure. Official warnings specifically mention reports of severe hypotension (low blood pressure) in certain patient groups and changes in blood pressure associated with symptoms of Serotonin Syndrome.

Q: Is Duocetz considered a new drug or has it been available for a while?

A: The active ingredients used in Duocetz have been available and regulated for many years. For instance, the tramadol component received initial FDA approval in 1995, and the fixed-dose combination product is well-established in regulatory systems.

Q: How is Duocetz different from other treatments for the same condition?

A: Duocetz is officially classified as a fixed-dose combination product containing two active ingredients: an opioid analgesic component (tramadol) and a non-opioid analgesic (acetaminophen). This dual composition is known to provide a unique, complementary mechanism of action to modulate pain signaling, distinguishing it from single-ingredient treatments.

Q: Are there any specific foods or drinks to avoid while taking Duocetz?

A: Official regulatory information states that Duocetz may be taken with or without food. There are no specific food items or non-alcoholic beverages that are restricted when taking this medication.

Q: Are there different strengths or dosages of Duocetz available?

A: The fixed-dose combination product is regulated and marketed in specific strengths. For example, it is commonly available as a tablet containing 37.5 mg of Tramadol Hydrochloride combined with 325 mg of Acetaminophen. Other dosage strengths may be regulated in different markets.

Q: Is Duocetz habit-forming or does it cause withdrawal symptoms?

A: Official safety information indicates that the tramadol component carries a risk of physical dependence and may be considered habit-forming, especially with prolonged use. Abrupt discontinuation of the medicine in a physically dependent patient can result in withdrawal symptoms.

Q: What is the long-term data available on using Duocetz?

A: The primary clinical research supporting the fixed-dose combination consists of short-term (acute pain) and intermediate-term (up to three months) studies. Regulatory reviews note that evidence regarding the product's long-term effectiveness and safety in chronic pain management remains limited and is considered inconsistent across trials.

Q: Has Duocetz been studied in clinical trials with children?

A: Regulatory warnings state the medicine is contraindicated in children under 12 years of age and is generally approved only for use in adults and adolescents aged 12 and older. Available registration trials reviewed by regulatory bodies typically involved adult populations.

Q: Do many people stop taking Duocetz because of side effects?

A: Clinical trial summaries and systematic reviews have noted that patient discontinuation rates were reported as higher in groups receiving this fixed-dose combination compared to placebo. Non-serious adverse effects were reported as a frequent reason for discontinuation during these studies.

Q: Can Duocetz change my mood or energy levels?

A: Official labeling lists changes in mood and sleepiness as documented side effects. Specifically, symptoms like nervousness (a change in mood) and somnolence (drowsiness or sleepiness, affecting energy levels) have been reported in patients taking the medicine.

Q: Why do official documents emphasize talking to a doctor before suddenly stopping Duocetz?

A: Official labeling contains warnings that abruptly discontinuing the medicine in a physically dependent patient has resulted in serious withdrawal symptoms, uncontrolled pain, and, in some cases, instances of suicide. Official guidance indicates that the dose is required to be reduced gradually under professional supervision.

Q: What should I do if I think Duocetz is not working for me?

A: Regulatory guidance describes the importance of informing the prescriber if the physical discomfort increases, gets worse, or if there is new pain or an increased sensitivity to pain after taking the medication. Such changes are typically evaluated by a healthcare professional.

Q: Does Duocetz need a special prescription or monitoring?

A: In the United States, Duocetz is classified as a Schedule IV controlled substance. This classification means it is subject to specific regulations regarding prescription validity, refills, and monitoring programs managed by the DEA and state-level prescription drug monitoring programs (PDMPs).

Q: Is Duocetz approved in countries outside of the United States?

A: Yes, the fixed-dose combination is regulated and approved for use in multiple global regions. For example, it is regulated across the European Union (EU), in addition to being regulated by the US FDA.

Q: Are there special considerations for people with kidney disease and Duocetz use?

A: Official guidance requires careful consideration for patients with kidney disease. The medicine is generally avoided in those with severe renal impairment; for those with mild to moderate impairment, use may require reduced doses and extended time between doses to account for altered clearance.

Q: What is the role of Duocetz in combination therapy?

A: The medicine's official role is as a fixed-dose combination, leveraging two active compounds. It may also be utilized as a component of a broader multimodal analgesia strategy in conjunction with other non-opioid medications, when professionally deemed appropriate.

Q: Why is it important to share a full medication list with the doctor when starting Duocetz?

A: Sharing a full medication list is critically important because Duocetz has documented clinically significant interactions with many substances, including CNS depressants and serotonergic drugs. These interactions can dramatically increase the risk of serious adverse events like Serotonin Syndrome or respiratory depression.

Q: What is the difference in purpose between Duocetz and a supplement I saw advertised?

A: Duocetz is a prescription medicine that has undergone rigorous review by regulatory bodies to document its safety profile, ingredients, and proven efficacy. Supplements, conversely, are regulated post-market and do not undergo the same mandatory pre-market evaluation for safety or effectiveness that prescription drugs do.

How should Duocetz be stored and disposed of?

How to Store and Dispose of Duocetz: Official Regulatory Guidance

Storage Requirements

Duocetz (Tramadol/Paracetamol combination) must be stored according to label instructions to maintain its quality and efficacy until the expiration date. Official regulatory guidance specifies the following controls:

  • Temperature: Store the medicine below 30 C (controlled room temperature).
  • Environmental Protection: Keep the product in its original, tightly closed container to protect it from moisture and light.
  • Handling: Do not freeze the product.
  • Child Safety: Packaging must comply with child-resistant regulations, and the product must be kept out of the sight and reach of children.

Disposal Requirements

Do not dispose of Duocetz by flushing it down a toilet or pouring it into a drain unless the drug is specifically listed on the official FDA flush list. The mandated disposal methods are:

  • Preferred Method: Use a drug take-back program or a mail-back option, which ensures proper handling.
  • Household Trash: If a take-back program is unavailable, mix the medicine with an unappealing substance (like dirt or used coffee grounds), place the mixture in a sealed bag or container, and discard it in the household trash. This method prevents unauthorized access.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Duocetz found in:

A-Z Index: